Immunoglobulin E and G antibodies two years after a booster dose of an aluminium-adsorbed or a fluid DT vaccine in relation to atopy

Pediatric Allergy and Immunology

Volumn 8, Issue 2, 1997, Pages 83-87

  Mark, Anders ^a   Björkstén, Bengt ^b   Granström, Marta ^c  

^a Department of Public Health ^*  (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aluminium adjuvant; Booster vaccination; Diphtheria tetanus (DT) vaccine; Immunoglobulin E

Indexed keywords

DIPHTHERIA TETANUS VACCINE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ARTICLE; ATOPY; BLOOD SAMPLING; HUMAN; HUMAN EXPERIMENT; IMMUNOGLOBULIN BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; REVACCINATION; SCHOOL CHILD; SYMPTOM;

EID: 0030840297     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.1997.tb00148.x     Document Type: Article

References (25)

1. GUPTA RK, RELYVELD EH. Adverse reactions after injection of adsorbed diphtheria-pertussis tetanus (DPT) vaccine are not only due to pertussis organisms or pertussis compounds in the vaccine. Vaccine 1991: 9: 699-702.
2. NAGEL J, SVEC D, WATERS T, FIREMAN P. IgE-synthesis in man. I. Development of specific IgE antibodies alter immunization with tetanus-diphtheria (Td) toxoids. J Immunol 1977: 118: 334-41.
3. PAUWELS R, BAZIN H, PLATTEAU B, VAN DER STRAETEN M. The influence of different adjuvants on the production of IgD and IgE antibodies. Ann Immunol 1979: 130C: 49-58.
4. BLENNOW M, GRANSTROM M, STRANDELL A. Adverse reactions after diphtheria tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination. Vaccine 1994: 12: 427-30.
5. MARK A, GRANSTROM M. The role of aluminium for adverse reactions and immunogenicity of diphtheria-tetanus booster vaccine. Acta Paediatr 1994: 83: 159-63.
6. MARK A. BJORKSTÉN B, GRANSTRÖM M. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine 1995: 13: 669-73.
7. PEARCE N, WEILAND KEIL U, LANGRIDGE P, ANDERSON P, STAACHAN D, BAUMAN A, et al. Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Respir J 1993: 6: 1455-61.
8. HEDENSKOG S, BJÖRKSTÉN B, BLENNOW M, GRANSTROM G, GRANSTROM M. Immunoglobulin E response to pertussis toxin in whooping cough and after immunisation with a whole-cell and an acellular pertussis vaccine. Int Arch Allergy Appl Immunol 1989: 89: 156-61.
9. MIYAMURA K, TAJIRI E, ITO A, MURAMATA R, KONO R. Microcell method for determination of diphtheria toxin and antitoxin titers using VERO cells II. Comparison with the rabbit skin method and practical application for seroepidemiological studies. J Biol Standard 1974: 2: 203-9.
10. HENRIKSEN CFM, GUN JW, NAGEL J, KREEFTENBERG JG. The toxin binding inhibition test as reliable in vitro alternative to the toxin neutralisation test in mice for the estimation of tetanus antitoxin in human sera. J Biol Standard 1988: 16: 287-97.
11. MARK A, CHRISTENSON B, GRANSTROM M, STRANDELL A. WICKBOM B, BÖTTIGER M. Immunity and immunization of children against diphtheria in Sweden. Eur J Microbiol Infect Dis 1989: 8: 214-19.
12. ÅBERG N, HESSELMAR B, ÅBERG B, ERIKSSON B. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 1995: 25: 815-19.
13. BRÅBACK L, KALVESTEN L. Urban living as a risk factor for atopic sensitization in Swedish schoolchildren. Paediatr Allergy Immunol 1991: 1: 14-19.
14. NILSSON L, KJELLMAN N-IM, BJÖRKSTEN B. Pertussis vaccination and atopic disease. Submitted for publication.
15. MATUHASI T, IKEGAMI H. Elevation of IgE antibody to tetanus toxin in individuals vaccinated with diphtheria-pertussis tetanus vaccine. J Infect Dis 1982: 146: 290.
16. COGNÉ M, BALLET JJ, SCHMITT C, BIZZINI B. Total and IgE antibody levels following booster immunisation with aluminium absorbed and nonabsorbed tetanus toxoid in humans. Ann Allergy 1985: 54: 148-51.
17. HAUS M, WEINBERG EG, MALHERBE D. Specific IgE antibodies to Bordetella pertussis after immunisation in infancy. Lancet 1988: I: 711.
18. BUSSE WW. Respiratory infections: Their role in airway responsiveness and the pathogenesis of asthma. J Allergy Clin Immunol 1990: 85: 671-83.
19. GRIFFIN DE. Immunologic abnormalities accompanying acute and chronic viral infections. Review Infect Dis 1991: 13 (suppl 1): 129-33.
20. NAGAYAMA Y, SAKURAI N. Clinical observations on lower respiratory tract infections with special reference to serum TgE levels. Pediatr Pulmonol 1991: 11: 44-8.
21. ODENT MR, CULPIN EE, KIMMEL T. Pertussis vaccination and asthma: Is there a link? JAMA 1994: 272: 592-3.
22. PAPPENHEIMER AM, EDSALL G, LAWRENCE HS, BANTON HJ. A study of reactions following administration of crude and purified diphtheria toxoid in an adult population. Am J Hyg 1950: 52: 353-70.
23. HEDENSKOG S, GRANSTRÖM M, OLIN P, TIRU M, SATO Y. A clinical trial of a monocomponent pertussis toxoid vaccine. Am J Dis Child 1987: 141: 844-7.
24. BLENNOW M, GRANSTROM M, BJÖRKSTÉN B. Immunoglobulin E response to pertussis toxin after vaccination with acellular pertussis vaccine. In Proc Sixth Intern Symp on Pertussis, (Ed. Manclark CR). DHHS Publication No. (FDA) 90-1164, 1990: 184-8.
25. ODELRAM H, GRANSTRÖM M, HEDENSKOG S, DUCHÉN K, BJÖRKSTÉN B. Immunoglobulin E and G responses to pertussis toxin after booster immunisation in relation to atopy, local reactions and alum content of the vaccines. Pediatr Allergy Immunol 1994: 5: 118-23.